P2RY2 and breast cancer: Proliferation of the breast cancer-derived cell line MCF-7 is decreased with high doses of ATP (over 100 μM), but lower doses of specific activation of P2Y2R increase cell proliferation, probably reflecting the action of different P2 receptor subtypes (Slater et al., 2004).